Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Phosphodiesterase Inhibitors and Prostaglandin Analogues in Dermatology: A Comprehensive Review Publisher Pubmed



Yazdanian N1 ; Mozafarpoor S2 ; Goodarzi A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Dermatology, Rasoul Akram Hospital, Iran University of Medical Sciences (IUMS), Tehran, Iran
  2. 2. Department of Dermatology, Skin Disease and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Dermatologic Therapy Published:2021


Abstract

Due to immune-mediated nature, medicines with immunomodulatory and anti-inflammatory effects can used to treat many dermatologic diseases. Phosphodiesterase and prostaglandins are involved in many inflammatory pathways that cause cutaneous disorders. Phosphodiesterase inhibitors (PDEIs) and prostaglandin analogues are currently employed to treat several dermatologic disorders. Given the few comprehensive reviews in this context, focusing on the dermatologic applications and efficacy of these medicines appears valuable. The present comprehensive review was, therefore, performed on the applications of PDEIs and prostaglandin analogues in different cutaneous disorders. All the relevant articles were selected to perform this review by searching databases such as Medline, Google Scholar, Scopus, and Web of Science. Oral PDEIs, especially apremilast, is an effective medicine in psoriasis and a number of other cutaneous disorders such as vitiligo. Topical PDEIs, including crisaborole ointment 2%, is a safe and effective treatment in atopic dermatitis. Prostaglandin analogues, especially their topical forms such as latanoprost and bimatoprost, have different applications in cutaneous disorders, including pigmentary disorders, especially vitiligo and hair repigmentation; for instance, bimatoprost is used for eyelash repigmentation. Prostaglandin analogues are also used in alopecia, including androgenetic alopecia and alopecia areata. Oral (apremilast) and topical (crisaborole) PDEIs and topical prostaglandin analogues, including latanoprost and bimatoprost, were found safe and effective in different skin diseases. In terms of efficiency and safety, these medicines compete with other medications of similar use even with higher efficacy and fewer side effects that necessitate further studies. © 2020 Wiley Periodicals LLC.
6. Prostaglandins in Glaucoma, Journal of Isfahan Medical School (2009)
Experts (# of related papers)
Other Related Docs
9. The Effect of Methotrexate 1% Topical Gel on Psoriasis, Journal of Isfahan Medical School (2012)
12. The Efficiency of Florabile Syrup on Intensity of Psoriasis Rashes, Journal of Isfahan Medical School (2021)
15. The Efficacy of 1% Metronidazole Gel in Facial Seborrheic Dermatitis: A Double Blind Study, Indian Journal of Dermatology, Venereology and Leprology (2006)
19. Role of Menthol in Treatment of Candidial Napkin Dermatitis, World Journal of Pediatrics (2011)